LifeVantage to Present at ICR XChange Conference

SALT LAKE CITY, Jan. 4, 2012 -- LifeVantage Corporation, maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson, the Company's President and Chief Executive Officer, will be presenting at the 14th Annual ICR XChange Conference, to be held on January 11-12, 2012, at The Fontainebleau Hotel in Miami Beach, Florida.

The LifeVantage investor presentation is scheduled for Thursday, January 12, 2012, at 9:25 am Eastern Time. The presentation will be webcast live and archived on the Investor Info portion of the Company's website.

About ICR XChange

The ICR XChange is one of the largest and most unique investor conferences of the year, and is open to institutional portfolio managers and analysts, sell-side research analysts, investment bankers from sponsoring firms only, private equity professionals, select media and invited guests of ICR. The event is expected to feature presentations by nearly 180 public and private companies, as well as, a variety of discussion panels and keynote presentations. Last year's attendance exceeded 1,500 institutional, corporate and media attendees, and this January ICR is expecting even greater participation. CNBC is also expected to broadcast live at the event for the sixth consecutive year.

 

More LifeVantage News and Articles

 

LifeVantage Profile

Create a Free LifeVantage Rep Listing